Oral Idasanutlin in Patients with Polycythemia Vera.
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood.2018893545
Abstract: A limited number of drugs are available to treat patients with polycythemia vera (PV) and essential thrombocythemia (ET). We attempted to identify alternative agents that may target abnormalities within malignant hematopoietic stem and progenitor cells… read more here.
Keywords: oral idasanutlin; polycythemia vera; idasanutlin patients; patients polycythemia ... See more keywords